Cero Therapeutics Holdings, Stock Buy Hold or Sell Recommendation
| CERO Stock | 0.07 0.01 8.42% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding CERo Therapeutics Holdings, is 'Strong Sell'. The recommendation algorithm takes into account all of CERo Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out CERo Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as CERo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards CERo Therapeutics Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
CERo |
Execute CERo Therapeutics Buy or Sell Advice
The CERo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CERo Therapeutics Holdings,. Macroaxis does not own or have any residual interests in CERo Therapeutics Holdings, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CERo Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
CERo Therapeutics Trading Alerts and Improvement Suggestions
| CERo Therapeutics is way too risky over 90 days horizon | |
| CERo Therapeutics has some characteristics of a very speculative penny stock | |
| CERo Therapeutics appears to be risky and price may revert if volatility continues | |
| CERo Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| CERo Therapeutics Holdings, was previously known as Phoenix Biotech Acquisition and was traded on NASDAQ Exchange under the symbol PBAX. | |
| Net Loss for the year was (2.54 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| CERo Therapeutics generates negative cash flow from operations | |
| CERo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 13.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Cero Therapeutics sees 383,369 in stock sales by YK Bioventures |
CERo Therapeutics Returns Distribution Density
The distribution of CERo Therapeutics' historical returns is an attempt to chart the uncertainty of CERo Therapeutics' future price movements. The chart of the probability distribution of CERo Therapeutics daily returns describes the distribution of returns around its average expected value. We use CERo Therapeutics Holdings, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CERo Therapeutics returns is essential to provide solid investment advice for CERo Therapeutics.
| Mean Return | 1.63 | Value At Risk | -18.18 | Potential Upside | 35.00 | Standard Deviation | 26.57 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CERo Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CERo Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CERo Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CERo Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CERo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.56 | |
β | Beta against Dow Jones | 0.59 | |
σ | Overall volatility | 27.13 | |
Ir | Information ratio | 0.06 |
CERo Therapeutics Volatility Alert
CERo Therapeutics Holdings, is showing large volatility of returns over the selected time horizon. CERo Therapeutics Holdings, is a penny stock. Although CERo Therapeutics may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in CERo Therapeutics Holdings,. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on CERo instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.CERo Therapeutics Fundamentals Vs Peers
Comparing CERo Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CERo Therapeutics' direct or indirect competition across all of the common fundamentals between CERo Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as CERo Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CERo Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing CERo Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CERo Therapeutics to competition |
| Fundamentals | CERo Therapeutics | Peer Average |
| Return On Asset | -0.45 | -0.14 |
| Current Valuation | 12.73 M | 16.62 B |
| Shares Outstanding | 51.35 M | 571.82 M |
| Shares Owned By Insiders | 12.54 % | 10.09 % |
| Shares Owned By Institutions | 9.04 % | 39.21 % |
| Number Of Shares Shorted | 5.83 M | 4.71 M |
| EBITDA | (2.44 M) | 3.9 B |
| Net Income | (2.54 K) | 570.98 M |
| Total Debt | 1.55 M | 5.32 B |
| Book Value Per Share | (0.52) X | 1.93 K |
| Cash Flow From Operations | (1.52 K) | 971.22 M |
| Short Ratio | 0.23 X | 4.00 X |
| Earnings Per Share | (1.19) X | 3.12 X |
| Number Of Employees | 8 | 18.84 K |
| Beta | -0.44 | -0.15 |
| Market Capitalization | 4.79 M | 19.03 B |
| Total Asset | 8.56 M | 29.47 B |
| Retained Earnings | (14.2 M) | 9.33 B |
| Working Capital | 5.91 M | 1.48 B |
| Net Asset | 8.56 M |
Note: Disposition of 1570947 shares by Yk Bioventures Opportunities Gp I, Llc of CERo Therapeutics at 0.09 subject to Rule 16b-3 [view details]
CERo Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CERo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2 M | |||
| Daily Balance Of Power | (0.65) | |||
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 0.0731 | |||
| Day Typical Price | 0.0719 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About CERo Therapeutics Buy or Sell Advice
When is the right time to buy or sell CERo Therapeutics Holdings,? Buying financial instruments such as CERo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CERo Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Check out CERo Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.